// App-Quantinova.ai

P018 : Non-alcoholic fatty liver disease in spondyloarthritis: identifying patients on therapy at high risk of serious liver disease

Researchers

Presenter

  • Stephanie R Harrison

Principal Investigators

  • Udvitha Nandasoma

  • Richard Parker

  • Chenchu Chimakurthi

  • Philip Laws

  • Andrew Barr

  • Claire Vandevelde

  • Helena Marzo-Ortega

  • Jane Freeston

Medical Centers

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Endocrine/metabolic Diseases (ME)

  • Gastroenterology (GU)

  • Musculoskeletal

Disease

  • Nonalcoholic fatty liver disease

  • Spondyloarthritis

  • Fatty Liver Disease

  • Hepatitis B

  • Cirrhosis

  • Diabetes

Biomarkers

  • Aspartate aminotransferase

  • Alanine transaminase

  • Human albumin

  • Body mass index

Drug/Treatment

  • Methotrexate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved